View more on these topics

Swiss Re sceptical about insurers&#39 use of genetic tests

Swiss Re Life & Health says it remains sceptical about how insurers will use genetic testing.


The company has welcomed the Government&#39s response to the Human Genetic Advisory Committee report but says that its own research found that 66 per cent of people felt they should not be under obligation to share the results of genetic tests.


Swiss Re head of research Peter Maynard says: &#34We are concerned about how insurers handle and use genetic information but equally, life companies need to be able to write business in a way that involves fairness from and to both parties to the policy.&#34

Recommended

Portman predicts housing market downturn in southern England

Portman Building Society says that uncertainty in the job market and talk of recession are causing a market slowdown in the south of England&#39s housing market.The building society&#39s third quarter residential property review finds that house prices in the south of England are levelling out with increases recorded at less than 1 per cent.The research […]

Scottish Widows launches Consensus Mixed Assurance Fund

Scottish Widows is launching a Consensus Mixed Assurance Fund investing in a portfolio of equities, gilts, fixed-interest stocks and cash. The fund will alter its weightings according to managed fund sector averages investing from a choice of five tracker funds. A Consensus Bond is available for lump sum investments offering a 1 per cent allocation […]

Newsletter

News and expert analysis straight to your inbox

Sign up

Comments

    Leave a comment